The government of Japan is assessing the costs and benefits of developing an integrated database for infectious diseases such as COVID-19 with the aim of facilitating quicker responses to future epidemics and assisting researchers in vaccine development.
The proposed database will contain information and medical materials such as blood and mucus samples of infected participants. The National Institute of Infectious Disease, currently responsible for analysing the genetic information of COVID-19, and the National Centre for Global Health and Medicine, which has been conducting COVID-19 symptom studies, would run the database together to produce a single data source. The government is also planning to review the law on infectious diseases in order to strengthen research and make study results available to the public.
For more information, please see the Japan Times article.